Used in biomedical research to quantify levels of endogenous secretory receptor for advanced glycation end products (esRAGE) in human biological samples such as serum, plasma, or cell culture supernatants. This ELISA kit enables researchers to study the role of esRAGE in inflammatory processes, oxidative stress, and metabolic disorders including diabetes, cardiovascular diseases, and neurodegenerative conditions. By measuring esRAGE concentrations, scientists can assess its potential as a biomarker for disease progression or response to therapy. The assay is valuable in clinical research settings investigating chronic inflammatory diseases and age-related pathologies.